Literature DB >> 20952658

The biological paths of IL-1 family members IL-18 and IL-33.

Dirk E Smith1.   

Abstract

Cytokines are key mediators of the immune system, and few have been more thoroughly studied than those of the IL-1 family. IL-1α and IL-1β are the founding members and now celebrate 25 years since their cloning. In that time, IL-1-directed research has illuminated many aspects of cytokine biology and innate immunity. The family is now recognized to include 11 total members, including IL-18 and IL-33, which are the topic of this review. These two inflammatory cytokines are expressed broadly, and their actions influence a variety of physiologic responses involved in inflammation and immunity. The purpose of this article is not to provide an exhaustive review of IL-18 and IL-33 but rather, to summarize what is known about their key functions and to provide perspective on their similarities and differences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952658     DOI: 10.1189/jlb.0810470

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  44 in total

Review 1.  Interleukin-33 biology with potential insights into human diseases.

Authors:  Gaby Palmer; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2011-04-26       Impact factor: 20.543

2.  Interleukin-18: the master regulator driving destructive and remodeling processes in the lungs of patients with chronic obstructive pulmonary disease?

Authors:  Takahiro Nakajima; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2012-06-01       Impact factor: 21.405

3.  Murine mast cells secrete and respond to interleukin-33.

Authors:  Hui-Ying Tung; Beverly Plunkett; Shau-Ku Huang; Yufeng Zhou
Journal:  J Interferon Cytokine Res       Date:  2013-09-12       Impact factor: 2.607

4.  Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1.

Authors:  Chauncey J Spooner; Justin Lesch; Donghong Yan; Aly A Khan; Alex Abbas; Vladimir Ramirez-Carrozzi; Meijuan Zhou; Robert Soriano; Jeffrey Eastham-Anderson; Lauri Diehl; Wyne P Lee; Zora Modrusan; Rajita Pappu; Min Xu; Jason DeVoss; Harinder Singh
Journal:  Nat Immunol       Date:  2013-10-20       Impact factor: 25.606

5.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

Review 6.  Implications for Interleukin-33 in solid organ transplantation.

Authors:  Quan Liu; Hēth R Turnquist
Journal:  Cytokine       Date:  2013-03-27       Impact factor: 3.861

7.  Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.

Authors:  Lijuan Wang; Yanchun Quan; Yongfang Yue; Xueyuan Heng; Fengyuan Che
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 8.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22

Review 9.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

10.  Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.

Authors:  Milena Hristova; Aida Habibovic; Carmen Veith; Yvonne M W Janssen-Heininger; Anne E Dixon; Miklos Geiszt; Albert van der Vliet
Journal:  J Allergy Clin Immunol       Date:  2015-11-17       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.